Synthesis, characterization and inhibitory potency of two oxono and thiono analogues of phosphoramidate compounds on acetylcholinesterase

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 21, Issue 5, 2006, Pages 521-525

  Gholivand, Khodayar ^a   Mojahed, Fresia ^a   Salehi, Marjan ^a   Naderi Manesh, Hossein ^a   Khajeh, Khosro ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Human erythrocyte acetylcholinesterase; IC50 value; Inhibition; Ki value; Oxono and thiono phosphoramidate; Pralidoxime; Reactivation

Indexed keywords

ACETYLCHOLINESTERASE; OBIDOXIME; PHOSPHORAMIDIC ACID DERIVATIVE; PRALIDOXIME;

ARTICLE; BINDING AFFINITY; CARBON NUCLEAR MAGNETIC RESONANCE; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; ENZYME REACTIVATION; ERYTHROCYTE; HUMAN; HUMAN CELL; IC 50; INFRARED SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ACETYLCHOLINESTERASE; AMIDES; CHOLINESTERASE INHIBITORS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; OXYGEN; PHOSPHORIC ACIDS; SPECTROPHOTOMETRY, INFRARED; SULFHYDRYL COMPOUNDS;

EID: 33751072905     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360600748524     Document Type: Article

References (27)

1. Taylor, P. (1985) Anticholinesterase Agents 7th ed.. New York: Mc Milam Press.
2. Fukuto, TR. (1971) Health Org, 44, pp. 31-41.
3. Eto, M. (1974) Organophosphorus Pesticides, Organic and Biological Chemistry. Florida: CRC Press.
4. Pardio, VT and Ibarra, N and Rodriguez, MA. (2001) J Agric Food Chem, 49, pp. 6057-6062.
5. Quin, LD. (2000) A Guide to Organophosphorus Chemistry. New York: John Wiley & Sons. Inc, Publication.
6. Clothier, B and Johnson, MK and Reine, E. (1981) Biochim Biophys Acta, 660, pp. 306-316.
7. Lee, HS and Kim, YA and Cho, YA and Lee, YT. (2002) Biosensor Chemosphere, 46, pp. 571-576.
8. Maxwell, DM and Brecht, KM. (1992) Chem Res Toxicol, 5, pp. 66-71.
9. Thompson, CM and Frich, JA and Natke, BC and Hansen, L. (1989) Chem. Res Toxicol, 2, pp. 386-391.
10. Vilanova, E and Johnson, MK and Vicedo, JL. (1987) Physiol, 281, pp. 224-238.
11. Langenberg, JP and De Jong, LPA and Otto, MF and Benschop, HP. (1988) Bull WHO, 44, pp. 31-42.
12. Bayiess, AV and Millner, OS. (1980) U.S. Patent, 4, pp. 182-881.
13. Sihotang, K. (1974) Biochim Biophys Acta, 370, pp. 468-476.
14. Ellman, GL and Courtney, KD and Andres, V and Featherstone, RM. (1961) Biochem Pharmacol, 7, pp. 88.
15. De Jong, LPA and Wolring, GZ and Benschop, HP. (1982) Arch Toxicol, 49, pp. 175-184.
16. Quin, LD. (1994) Phosphorus-31 NMR Spectral Properties in Compound Characterization and Structural Analysis. New York: VCH Publishers, Inc.
17. Gholivand, K and Shariatinia, Z and Ghadimi, S and Mojahed, F and Madani-Alizadegan, A and Khajeh, K and Naderi-manesh, H. (2004) J Enz Inhib Med Chem, 19, pp. 403-407.
18. Thompson, CM and Suarez, AI and Rodriguez, OP. (1996) Chem Res Toxicol, 9, pp. 1325-1332.
19. Sussman, JL and Harel, M and Frolow, F and Oefner, C and Gddman, A and Toker, L and Silman, I. (1991) Science, 253, pp. 872-879. (Washington, D. C.)
20. Ashani, Y and Wins, P and Wilson, IB. (1972) Biochim Biophys Acta, 284, pp. 427-434.
21. Corbridge, DEC. (1995) Phosphorus 5th ed.. Amsterdam: Elsevier.
22. Ryu, S and Lin, J and Thompson, CM. (1991) Chem Res Toxicol 4, pp. 517-520.
23. Jokanovic, M and Maksimovic, M and Kilibarda, V and Jovanovic, D. (1996) Toxicol Lett, 85, pp. 35-39.
24. Barak, D and Ordentlich, A and Kaplan, D and Barak, R and Mizrahi, D and Kronman, C and Segall, Y and Velan, B and Shafferman, A. (2000) Biochemistry, 39, pp. 1156-1161.
25. Elhanay, E and Ordentlich, A and Dgany, O and Kaplan, D and Segall, Y and Barak, R and Velan, B and Shafferman, A. (2001) Chem Res Toxicol, 14, pp. 912.
26. Quistad, GB and Zhang, N and Spaks, SE and Casida, JE. (2000) Biochemistry, 13, pp. 652-657.
27. Wong, L and Radie, Bruggemann RIM and Hosea, N and Berman, HA and Taylor, P. (2000) Biochemistry, 39, pp. 5750-5757.